Adviser
TD Cowen.
Financial adviser, Fairness opinion on 6 live deals, from 14 Jul 2025 to 12 Mar 2026. Also written as TD Cowen LLP.
06Live deals
06Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 12 Mar 2026 | Enodia Therapeutics SAS / Kezar Life Sciences, Inc. | Agreement signed |
| Healthcare |
| 13 Feb 2026 | Lumine Group US Holdco Inc. / Synchronoss Technologies, Inc. | Closed |
| Technology |
| 9 Jan 2026 | XRA 7 Corp. / Generation Bio | Agreement signed |
| Healthcare |
| 6 Jan 2026 | Day One / Mersana | Closed |
| Healthcare |
| 12 Nov 2025 | Day One Biopharmaceuticals, Inc. / Mersana Therapeutics, Inc. | Agreement signed |
| Healthcare |
| 14 Jul 2025 | TTAM Research Institute / 23andMe Holding Co. | Closed |
| Healthcare |
By year, sector and stage
| 2026 | 4 |
|---|---|
| 2025 | 2 |
| Healthcare | 5 |
|---|---|
| Technology | 1 |
| Agreement signed | 3 |
|---|---|
| Closed | 3 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Fenwick & West LLP | 1 | 1 | 0 |
| Goodwin Procter LLP | 1 | 1 | 0 |
| Gordon Dyal & Co., LLC | 1 | 1 | 0 |
| Dorr LLP | 1 | 0 | 1 |
| Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP | 1 | 0 | 1 |
| Quinn Emanuel Urquhart & Sullivan LLP | 1 | 0 | 1 |